Drug Shortages: Accumulating Federal Legislation as an Underlying Cause
Research output: Working paper › Research › peer-review
Standard
Drug Shortages: Accumulating Federal Legislation as an Underlying Cause. / Darrow, Jonathan; Fox, Erin R. ; Minssen, Timo.
2024.Research output: Working paper › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - UNPB
T1 - Drug Shortages: Accumulating Federal Legislation as an Underlying Cause
AU - Darrow, Jonathan
AU - Fox, Erin R.
AU - Minssen, Timo
PY - 2024
Y1 - 2024
N2 - This article considers the role ofwell-intentioned legislation over the past fifty years, including the 1984 HatchWaxman Act, the 2003 Medicare Modernization Act, and 2012 Generic DrugUser Fee Act, and the 2015 Bipartisan Budget Act in inadvertently squeezingprofitability out of the generic drug market and thereby serving as a true rootcause of many drug shortages. Also considered are the potential effects on drugshortages of more recent legislation, including the 2021 American Rescue ActPlan and the 2022 Inflation Reduction Act.
AB - This article considers the role ofwell-intentioned legislation over the past fifty years, including the 1984 HatchWaxman Act, the 2003 Medicare Modernization Act, and 2012 Generic DrugUser Fee Act, and the 2015 Bipartisan Budget Act in inadvertently squeezingprofitability out of the generic drug market and thereby serving as a true rootcause of many drug shortages. Also considered are the potential effects on drugshortages of more recent legislation, including the 2021 American Rescue ActPlan and the 2022 Inflation Reduction Act.
KW - Faculty of Law
KW - drug shortages
KW - Innovation
KW - Access
KW - Prizes
M3 - Working paper
BT - Drug Shortages: Accumulating Federal Legislation as an Underlying Cause
ER -
ID: 398910994